Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Inventory Average: 2021-2025

Historic Inventory Average for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $11.3 million.

  • GeneDx Holdings' Inventory Average rose 6.68% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $9.7 million for FY2024, which is 13.43% down from last year.
  • Per GeneDx Holdings' latest filing, its Inventory Average stood at $11.3 million for Q3 2025, which was down 8.51% from $12.3 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Inventory Average registered a high of $42.9 million during Q3 2022, and its lowest value of $9.1 million during Q4 2023.
  • In the last 3 years, GeneDx Holdings' Inventory Average had a median value of $11.0 million in 2024 and averaged $11.1 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 42.24% in 2022, then plummeted by 75.66% in 2023.
  • GeneDx Holdings' Inventory Average (Quarterly) stood at $32.3 million in 2021, then dropped by 10.51% to $28.9 million in 2022, then crashed by 68.66% to $9.1 million in 2023, then grew by 18.17% to $10.7 million in 2024, then rose by 6.68% to $11.3 million in 2025.
  • Its Inventory Average stands at $11.3 million for Q3 2025, versus $12.3 million for Q2 2025 and $11.7 million for Q1 2025.